Kura Oncology reports 50% response rate
Kura Oncology (NASDAQ:KURA) reported 33%–50% response rates for darlifarnib plus cabozantinib among 34 evaluable advanced kidney-cancer patients.

Finance journalist at Grafa with years of experience covering Asia-Pacific financial markets at S&P Global, Mortgage Ezy, and GMA Network.
Kura Oncology (NASDAQ:KURA) reported 33%–50% response rates for darlifarnib plus cabozantinib among 34 evaluable advanced kidney-cancer patients.
AstraZeneca (NYSE:AZN) reported second-quarter core EPS of $2.63, up 21%, as oncology and rare-disease sales grew.
Coinbase CEO Brian Armstrong said artificial intelligence agents are likely to complete more transactions than humans in the future, with cryptocurrencies powering those payments.
Anax Metals (ASX:ANX) has commenced front-end engineering design work for its 80%-owned Whim Creek Copper Project.
Google has expanded Anthropic's Claude AI assistant to access cryptocurrency wallet data through its platform.
Carrier Global (NYSE:CARR) has signed a definitive agreement to sell its NORESCO energy-efficiency business to OPTERRA Energy Services, a subsidiary of LS Power, in a transaction expected to close shortly.
Botanix Pharmaceuticals (ASX:BOT) generated $10.1 million in net revenue for the fourth quarter of fiscal 2026.
Upbit has added two major decentralised finance (DeFi) tokens to its South Korean won (KRW) trading market.
Verbrec (ASX:VBC) confirmed its FY26 revenue guidance of $120 million alongside new financial metrics for FY27.
Equinix (NASDAQ:EQIX) has appointed Jarrod Nink as managing director for Australia to lead its regional expansion.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy